Meet the Leukemia/Lymphoma Team
Team Co-Leaders
| Basic Science | Clinical |
| Thomas P. Loughran, M.D. | David F. Claxton, M.D. |
The Leukemia and Lymphoma Team meets monthly to discuss research and operational issues. A multidisciplinary group also meets weekly to discuss new cases of leukemia, lymphoma, and multiple myeloma. This is attended by radiologists, hematopathologists, and clinical hematologists/oncologists.
Clinical research includes ongoing investigator-initiated studies in non-ablative allogeneic transplantation for hematological malignancies, and protocols in therapy of relapsing leukemias and lymphomas. Investigators in attendance include clinical investigators, hematopathologists, and basic scientists as indicated. NIH funded studies in treatment of large granular lymphocytic leukemia and myelodysplastic syndrome also underway.
Translational research in hematological malignancies include laboratory and translational studies of immunotherapy for leukemias, and developmental therapeutics including agents directed at sphingolipid metabolism.
Basic science: Basic studies in the biology of large granular lymphocytic leukemia are led by Dr. Loughran.
Team Members
| Click on the member's name to see a biosketch, if available.
| ||
| Ashraf Abou-Elella, M.D. James Ballard, M.D. Michael Bayerl, M.D. Chandra Belani, M.D. Vincent Chau, Ph.D. Hua Cheng, M.D. Loren Clarke, M.D. David Claxton, M.D. | Catherine Coleman, Ph.D. Joseph Drabick, M.D. W. Christopher Ehmann, M.D. John Flanagan, Ph.D. Andrew Freiberg, M.D. Sergi Grigoryev, Ph.D. Thomas Loughran, M.D. Barbara Miller, M.D. | John Neely, M.D. Thomas Nifong, M.D. Gavin Robertson, Ph.D. Witold Rybka, M.D. Christopher Siedlecki, Ph.D. Henry Wagner, Jr., M.D. Eric Walker, M.D. |
